Drugs News and Research

RSS

World Health Organization, Sanofi sign new agreement to eliminate neglected tropical diseases

The World Health Organization (WHO) and Sanofi – one of the world's leading pharmaceutical companies – have signed a new agreement for donations of medicines to sustain specific efforts to eliminate neglected tropical diseases (NTDs).

15 Dec 2020

Research could lead to potential new treatments for mutant RAS-driven cancers

Scientists have dedicated huge amounts of time and resources to better understanding the causes and mechanisms of cancer growth.

15 Dec 2020

New class of targeted cancer drugs may prove effective in treating common types of leukemia

A new study by researchers in Cleveland Clinic's Taussig Cancer Institute and Lerner Research Institute describes a novel class of targeted cancer drugs that may prove effective in treating certain common types of leukemia.

15 Dec 2020

Abnormalities in bone microarchitecture linked to risk of complications after spinal fusion surgery

The microscopic structure of bone appears to predict which patients will experience poor outcomes after spinal fusion, according to a new study by researchers at Hospital for Special Surgery (HSS) in New York City.

15 Dec 2020

FDA issues emergency use authorization for first fully at-home OTC COVID-19 diagnostic test

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first over-the-counter (OTC) fully at-home diagnostic test for COVID-19.

15 Dec 2020

Electrical impulses may help reduce the complications of arterial hypertension

Electrical impulses applied to a particular branch of the vagus nerve could be used in the future to reduce complications of arterial hypertension.

15 Dec 2020

First enzyme-driven biocatalytic production of nucleic acid building blocks

Researchers from TU Graz and acib succeed in the first enzyme-driven biocatalytic synthesis of nucleic acid building blocks. This facilitates the development of antiviral agents and RNA-based therapeutics.

15 Dec 2020

Researchers develop new technology for efficient production of monoclonal antibodies

Proteins in biopharmaceutical productions are usually separated and purificated through the expensive chromatography technique. European researchers are developing an innovative membrane crystallization technology to overcome the issue and make the production of monoclonal antibodies more efficient.

15 Dec 2020

Mologic and the University of Liverpool collaborate to develop a rapid diagnostic test for common agricultural parasite

Mologic today announced it is in the final developmental stages of a pen-diagnostic test with the University of Liverpool.

15 Dec 2020

Scientists empower wireless sensors with vision abilities to fight viruses

Current and former early-career scientists share their stories and tell how Europe has bet on them, making their high-risk research possible: from intelligent wireless sensors with vision abilities to RNA-based techniques to fight viruses, from the mathematical formulas of the MRI waves to optoceutics, the new technique that uses light to repair the heart after a stroke.

15 Dec 2020

FDA approves first IGA in GalSafe pigs for human food, promising therapeutic uses

Today, the U.S. Food and Drug Administration approved a first-of-its-kind intentional genomic alteration (IGA) in a line of domestic pigs, referred to as GalSafe pigs, which may be used for food or human therapeutics.

15 Dec 2020

New alliance seeks to tackle the plague of falsified medical products

COVID-19 has spawned a "stark rise" in the global circulation of fake medical products relating to the pandemic, experts warn as they launch an alliance aimed at tackling the scourge.

14 Dec 2020

Recommendations to prevent SARS-CoV-2 spread via aerosols in hospitals and nursing homes

A variety of measures are necessary to prevent the spread of the coronavirus SARS-CoV-2 in hospitals and nursing homes. It is particularly important to develop an appropriate strategy to protect healthcare workers from airborne transmission.

14 Dec 2020

Multisystem immune-related adverse events linked with improved survival from immunotherapy in NSCLC

The results of a large, retrospective study of patients who received a form of immunotherapy for non-small cell lung cancer (NSCLC) revealed that patients may get more than one immune-related side effect, and identified a correlation between these multisystem immune-related adverse events (irAEs) and improved patient survival.

14 Dec 2020

New combination therapy has potential to treat aggressive cancers with common mutations

Scientists have long known that therapies that target the cancer-driving MAPK pathway are only effective in a handful of cancers with specific mutations in a cancer gene called BRAF, and these cancers that initially respond to the therapy often end up developing resistance to the treatment, resulting in relapse for many patients.

14 Dec 2020

Drugs News and Research

World Health Organization, Sanofi sign new agreement to eliminate neglected tropical diseases

Research could lead to potential new treatments for mutant RAS-driven cancers

New class of targeted cancer drugs may prove effective in treating common types of leukemia

Abnormalities in bone microarchitecture linked to risk of complications after spinal fusion surgery

FDA issues emergency use authorization for first fully at-home OTC COVID-19 diagnostic test

Electrical impulses may help reduce the complications of arterial hypertension

First enzyme-driven biocatalytic production of nucleic acid building blocks

Researchers develop new technology for efficient production of monoclonal antibodies

Mologic and the University of Liverpool collaborate to develop a rapid diagnostic test for common agricultural parasite

Scientists empower wireless sensors with vision abilities to fight viruses

FDA approves first IGA in GalSafe pigs for human food, promising therapeutic uses

New alliance seeks to tackle the plague of falsified medical products

Recommendations to prevent SARS-CoV-2 spread via aerosols in hospitals and nursing homes

Multisystem immune-related adverse events linked with improved survival from immunotherapy in NSCLC

New combination therapy has potential to treat aggressive cancers with common mutations

RUDN chemists discover previously unknown derivatives of chitin

Remdesivir likely to be highly effective treatment for COVID-19

SARS-CoV-2 Nsp3 protease activity and nanobody inhibitor development

Research provides new insights into Glioblastoma invasiveness

Distant residues modulate the conformational opening in SARS-CoV-2 spike protein

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News